How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution! [electronic resource]

By: Contributor(s): Producer: 19960711Description: 779-81 p. digitalISSN:
  • 0027-8874
Subject(s): Online resources: In: Journal of the National Cancer Institute vol. 88
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Comment; Editorial

There are no comments on this title.

to post a comment.